Efficacy and safety of ripretinib vs. sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: A phase 2, multicenter, randomized, open-label study in China
Year: 2023
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: European Journal of Cancer
Authors: Jian Li, Jun Zhang, Yanqiao Zhang, Haibo Qiu, Yanbing Zhou, Yongjian Zhou, Xinhua Zhang, Ye Zhou, Yuping Zhu, Yong Li, Ming Wang, Kuntang Shen, Kaixiong Tao, Xin Wu, Haijiang Wang, Bo Zhang, Jiayu Ling, Yingjiang Ye, Xingye Wu, Hongyan Qu, Yue Ma, Xuelong Jiao, Hualong Zheng, Jiejie Jin, Zhuo Liu, Ming Tan, Yong Fang, Peng Zhang, Nan Zhang, Cheng Lei, Zhaolun Cai, Bin Liang, Zhangyan Peng, Zhao Huang, Juan Dong, Lin Shen
Institutions: Peking University Cancer Hospital, The Affiliated Yongchuan Hospital of Chongqing Medical University, Third Affiliated Hospital of Harbin Medical University, Sun Yat-sen University Cancer Center, Affiliated Hospital of Qingdao University, Union Hospital, The First Affiliated Hospital, Sun Yat-sen University, Fudan University Shanghai Cancer Center, Zhejiang Cancer Hospital, University of Chinese Academy of Sciences, Fourth Hospital of Hebei Medical University, Shanghai Jiao Tong University, Renji Hospital, Fudan University, Zhongshan Hospital, Wuhan Union Hospital, Huazhong University of Science and Technology, Chinese PLA General Hospital, Xinjiang Medical University, Tumor Hospital of Xinjiang Medical University, Sichuan University, West China Hospital of Sichuan University, Sun Yat-sen University, Sixth Affiliated Hospital of Sun Yat-sen University, Peking University People's Hospital
Language: English
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4388680604
